Ozagrel 100mg | ≥99%
CSNpharm
Ozagrel is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.
More Information Supplier PageOzagrel
Search Results
Diiodohydroxyquinoline 1g | ≥98%
CSNpharm
Diiodohydroxyquinoline is a quinoline derivative used in the treatment of amoebiasis.
More Information Supplier PageDiiodohydroxyquinoline
Diiodohydroxyquinoline 100mg | ≥98%
CSNpharm
Diiodohydroxyquinoline is a quinoline derivative used in the treatment of amoebiasis.
More Information Supplier PageDiiodohydroxyquinoline
Astragaloside A 5mg | ≥98%
CSNpharm
Astragaloside A is one of the major active constituents of Astragalus membranaceus in traditional Chinese medicine and has been widely used to treat ischemic diseases.
More Information Supplier PageAstragaloside A
Astragaloside A 50mg | ≥98%
CSNpharm
Astragaloside A is one of the major active constituents of Astragalus membranaceus in traditional Chinese medicine and has been widely used to treat ischemic diseases.
More Information Supplier PageAstragaloside A
Astragaloside A 10mg | ≥98%
CSNpharm
Astragaloside A is one of the major active constituents of Astragalus membranaceus in traditional Chinese medicine and has been widely used to treat ischemic diseases.
More Information Supplier PageAstragaloside A
Ozagrel 50mg | ≥99%
CSNpharm
Ozagrel is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.
More Information Supplier PageOzagrel
Ozagrel 10mg | ≥99%
CSNpharm
Ozagrel is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.
More Information Supplier PageOzagrel
Ozagrel 5mg | ≥99%
CSNpharm
Ozagrel is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.
More Information Supplier PageOzagrel
Leflunomide 100mg | ≥99%
CSNpharm
Leflunomide is a dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 2.5 μM, it is a disease-modifying antirheumatic drug (DMARD) and inhibits de novo pyrimidine synthesis.
More Information Supplier PageLeflunomide
